Literature DB >> 23410968

Molecular archeology: unearthing androgen-induced structural rearrangements in prostate cancer genomes.

Francesca Demichelis1, Levi A Garraway, Mark A Rubin.   

Abstract

In this issue of Cancer Cell, Weischenfeldt and colleagues report on the whole genome sequencing of 11 early-onset prostate cancers. Compared to elderly onset prostate cancer, these tumors demonstrate enrichment for androgen-driven structural rearrangements involving ETS family genes. This study confirms observations that prostate cancer manifests discrete genomic subclasses.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Year:  2013        PMID： 23410968      PMCID： PMC3630373          DOI： 10.1016/j.ccr.2013.01.019

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  10 in total

1.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Authors:  Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

2.  Commentary on "integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer." Weischenfeldt J, Simon R, Feuerbach L, Schlangen K, Weichenhan D, Minner S, Wuttig D, Warnatz HJ, Stehr H, Rausch T, Jäger N, Gu L, Bogatyrova O, Stütz AM, Claus R, Eils J, Eils R, Gerhäuser C, Huang PH, Hutter B, Kabbe R, Lawerenz C, Radomski S, Bartholomae CC, Fälth M, Gade S, Schmidt M, Amschler N, Haß T, Galal R, Gjoni J, Kuner R, Baer C, Masser S, von Kalle C, Zichner T, Benes V, Raeder B, Mader M, Amstislavskiy V, Avci M, Lehrach H, Parkhomchuk D, Sultan M, Burkhardt L, Graefen M, Huland H, Kluth M, Krohn A, Sirma H, Stumm L, Steurer S, Grupp K, Sültmann H, Sauter G, Plass C, Brors B, Yaspo ML, Korbel JO, Schlomm T, Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.: Cancer Cell 2013;23(2):159-70.

Authors:  Aria F Olumi
Journal:  Urol Oncol       Date:  2014-02       Impact factor: 3.498

3.  Oncogene-mediated alterations in chromatin conformation.

Authors:  David S Rickman; T David Soong; Benjamin Moss; Juan Miguel Mosquera; Jan Dlabal; Stéphane Terry; Theresa Y MacDonald; Joseph Tripodi; Karen Bunting; Vesna Najfeld; Francesca Demichelis; Ari M Melnick; Olivier Elemento; Mark A Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

Review 4.  Common gene rearrangements in prostate cancer.

Authors:  Mark A Rubin; Christopher A Maher; Arul M Chinnaiyan
Journal:  J Clin Oncol       Date:  2011-08-22       Impact factor: 44.544

5.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

6.  TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.

Authors:  Sven Perner; Francesca Demichelis; Rameen Beroukhim; Folke H Schmidt; Juan-Miguel Mosquera; Sunita Setlur; Joelle Tchinda; Scott A Tomlins; Matthias D Hofer; Kenneth G Pienta; Rainer Kuefer; Robert Vessella; Xiao-Wei Sun; Matthew Meyerson; Charles Lee; William R Sellers; Arul M Chinnaiyan; Mark A Rubin
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

7.  Induced chromosomal proximity and gene fusions in prostate cancer.

Authors:  Ram-Shankar Mani; Scott A Tomlins; Kaitlin Callahan; Aparna Ghosh; Mukesh K Nyati; Sooryanarayana Varambally; Nallasivam Palanisamy; Arul M Chinnaiyan
Journal:  Science       Date:  2009-10-29       Impact factor: 47.728

8.  Distinct genomic aberrations associated with ERG rearranged prostate cancer.

Authors:  Francesca Demichelis; Sunita R Setlur; Rameen Beroukhim; Sven Perner; Jan O Korbel; Christopher J Lafargue; Dorothee Pflueger; Cara Pina; Matthias D Hofer; Andrea Sboner; Maria A Svensson; David S Rickman; Alex Urban; Michael Snyder; Matthew Meyerson; Charles Lee; Mark B Gerstein; Rainer Kuefer; Mark A Rubin
Journal:  Genes Chromosomes Cancer       Date:  2009-04       Impact factor: 5.006

9.  The genomic complexity of primary human prostate cancer.

Authors:  Michael F Berger; Michael S Lawrence; Francesca Demichelis; Yotam Drier; Kristian Cibulskis; Andrey Y Sivachenko; Andrea Sboner; Raquel Esgueva; Dorothee Pflueger; Carrie Sougnez; Robert Onofrio; Scott L Carter; Kyung Park; Lukas Habegger; Lauren Ambrogio; Timothy Fennell; Melissa Parkin; Gordon Saksena; Douglas Voet; Alex H Ramos; Trevor J Pugh; Jane Wilkinson; Sheila Fisher; Wendy Winckler; Scott Mahan; Kristin Ardlie; Jennifer Baldwin; Jonathan W Simons; Naoki Kitabayashi; Theresa Y MacDonald; Philip W Kantoff; Lynda Chin; Stacey B Gabriel; Mark B Gerstein; Todd R Golub; Matthew Meyerson; Ashutosh Tewari; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

10.  Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer.

Authors:  G Schaefer; J-M Mosquera; R Ramoner; K Park; A Romanel; E Steiner; W Horninger; J Bektic; M Ladurner-Rennau; M A Rubin; F Demichelis; H Klocker
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-02-05       Impact factor: 5.554
  10 in total
  3 in total

Review 1.  Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned.

Authors:  Lisa M Lowenstein; Spyridon P Basourakos; Michelle D Williams; Patricia Troncoso; Justin R Gregg; Timothy C Thompson; Jeri Kim
Journal:  Nat Rev Clin Oncol       Date:  2019-03       Impact factor: 66.675

2.  Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.

Authors:  Manuel Luedeke; Antje E Rinckleb; Liesel M FitzGerald; Milan S Geybels; Johanna Schleutker; Rosalind A Eeles; Manuel R Teixeira; Lisa Cannon-Albright; Elaine A Ostrander; Steffen Weikert; Kathleen Herkommer; Tiina Wahlfors; Tapio Visakorpi; Katri A Leinonen; Teuvo L J Tammela; Colin S Cooper; Zsofia Kote-Jarai; Sandra Edwards; Chee L Goh; Frank McCarthy; Chris Parker; Penny Flohr; Paula Paulo; Carmen Jerónimo; Rui Henrique; Hans Krause; Sven Wach; Verena Lieb; Tilman T Rau; Walther Vogel; Rainer Kuefer; Matthias D Hofer; Sven Perner; Mark A Rubin; Archana M Agarwal; Doug F Easton; Ali Amin Al Olama; Sara Benlloch; Josef Hoegel; Janet L Stanford; Christiane Maier
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

3.  A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.

Authors:  Constantin Georgescu; Joshua M Corbin; Sandra Thibivilliers; Zachary D Webb; Yan D Zhao; Jan Koster; Kar-Ming Fung; Adam S Asch; Jonathan D Wren; Maria J Ruiz-Echevarría
Journal:  BMC Cancer       Date:  2019-05-06       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.